Retatrutide / 30 mg

Retatrutide is a novel triple receptor agonist under active investigation for metabolic research. This bulk 30 mg lyophilised vial offers maximum value per mg for extended research protocols. Third-party verified by HPLC and mass spectrometry. Certificate of Analysis included with every batch.

By purchasing, you confirm you are a qualified researcher and that this product will only be used for in-vitro laboratory research. Not for human or veterinary use.